Zelira Therapeutics (ZLDAF, $0.28) was one of the top gainers this week, climbing +2 to $0.28 per share. A.I.dvisor analyzed 832 stocks in the Biotechnology Industry over the last week and discovered that of them (7) trended up while of them (2) trended down.